Overview of Elevit Pronatal

Property	Description
Active ingredient	Multiple Vitamins and Minerals, including Iron and Folic Acid
Form	Film-coated Tablet
Pharmacological class	Nutritional Supplement / Vitamin-Mineral Complex
Common use	Prophylactic Nutritional Support
Manufacturer	Bayer

Elevit Pronatal is classified as a Nutritional Supplement and a Multivitamin and Multimineral Complex, defined pharmacologically as a Fixed-Combination Preparation intended for Prophylactic Nutritional Support. Its primary function is to supply a broad spectrum of essential micronutrients to the body to ensure the maintenance of crucial nutritional reserves during periods of heightened metabolic demand.

This preparation is positioned for women during the preconception, pregnancy, and lactation phases, utilizing a formulation of combined supplementation. This complex differs from single-entity supplements (like pure Iron or Folic Acid tablets) by addressing the need for multiple, balanced nutrients simultaneously in a single formulation.

Composition and General Purpose

The active components consist of a precise mixture of Multiple Vitamins and Multiple Minerals and trace elements. Key substances include essential vitamins such as the B-complex group, C, D, and E, alongside vital minerals like Iron, Calcium, Zinc, and Folic Acid. Balanced protein and energy supplementation is intended to improve outcomes for pregnant women and their babies.

The preparation is available as a stable and convenient Oral dosage form, specifically a Film-coated Tablet. Its constituent micronutrients, derived from a combination of synthetic and natural-derived sources, act as Metabolic Co-Factors, aiding numerous essential cellular metabolic processes. Key micronutrients like Folic Acid play a role in cell division and growth. The overall utility of this complex focuses on maintaining sufficient Nutritional Reserve Maintenance to help prevent nutritional deficiencies where dietary intake may be suboptimal or physiological demand is significantly increased.

Regulatory References

National Institutes of Health (NIH)

What side effects are possible with Elevit Pronatal?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety restrictions for Elevit Pronatal, based on government regulatory labeling. This information is descriptive and not intended as medical advice.

Adverse Reactions Scope

Common and Expected Effects: Most adverse reactions reported are non-serious and relate to the Gastrointestinal System. These include constipation, diarrhea, upset stomach, nausea, and vomiting.

Serious Reactions: Rare but clinically significant reactions include severe hypersensitivity or anaphylactic reactions (severe allergic response, including rash, swelling, or difficulty breathing). The label warns that these require immediate medical attention.

System-Organ Class	Examples of Reported Effects
Gastrointestinal Disorders	Constipation, diarrhea, nausea, upset stomach
Immune System Disorders	Severe hypersensitivity, anaphylactic reaction

Safety Restrictions and Warnings

Contraindications (Must Not Be Used): Elevit Pronatal is contraindicated in patients with a known hypersensitivity to any component, severe impaired renal function, existing hypervitaminosis D, hypercalcaemia, or iron/copper metabolism disorders.

Overdose Risk: The official label explicitly warns that the recommended dosage must not be exceeded. Overdose of components like Vitamin D or iron can be harmful, and chronic Vitamin D overdose carries a risk of harm to the fetus. Patients using other products containing high levels of vitamins and minerals should be cautious to avoid excessive total intake.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help

Domain	Official Regulatory Statements
Documented overdose presentations	Abrupt onset of uncharacteristic initial symptoms such as headache, confusion, and gastrointestinal disturbances (nausea, vomiting, diarrhea, and constipation) may be documented signs of acute overdose.
Physiological systems affected	The regulatory profile notes potential severe effects on the circulatory system, liver, and kidneys in the context of acute iron overdose, which is linked to fatal poisoning.
Dose-related or exposure-related factors	The primary exposure-related factor is the risk of accidental ingestion of iron-containing products.
Population-specific overdose notes	Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Chronic overdose of Vitamin D must also be avoided during pregnancy due to the risk of fetal harm through hypercalcaemia.
Emergency-response statements	If general symptoms occur, treatment must be stopped, and a health care professional consulted.
When immediate medical help is required	In case of accidental overdose, the mandated action is to call a doctor or Poison Control Center immediately.

Overdose Classifications (High-Level)

Classification	Official Regulatory Statement
Severity classification	Overdose of iron-containing products is classified as being associated with fatal poisoning in children.
Regulatory basis	The overdose profile is governed by official regulatory guidance and national medicines authority product labeling.
Overdose-context constraints	The product labeling states that no specific antidote is known.

Resulting Overdose Structure

Official overdose statements:

The most severe documented risk is fatal poisoning in children from the iron component, requiring an immediate call to emergency services.
Documented symptoms include headache and gastrointestinal disturbances, which necessitate consultation with a health professional.
The regulatory documentation specifies that no specific antidote is known for the product.

Connection to the overall overdose profile (3 sentences): Regulatory documentation defines the overdose profile primarily through the critical, life-threatening risk associated with the iron component, mandating the explicit warning regarding fatal poisoning in children. This structure emphasizes the specific circumstances and components that trigger regulator-mandated urgent action. For adult overdose, the profile requires stopping the product and consulting a healthcare professional upon the onset of general symptoms.

Therapeutic Uses of Elevit Pronatal

Elevit Pronatal is primarily used to address the increased nutritional demands of women who are planning a pregnancy, are pregnant, or are breastfeeding, providing supportive therapeutic benefit by supplementing key micronutrients. This focus on nutritional support is relevant for both maternal health and the baby's foundational development.

Supporting Foundational Development and Maternal Health

This supplement is used in situations involving certain distressing symptoms related to systemic imbalance by providing key micronutrients, such as Folic Acid and Iron. It is commonly used during pre-conception planning, gestation, and lactation, which are conditions characterized by periods of heightened nutrient requirements. The primary therapeutic benefit is to contribute to general support for the baby's development, which may assist with managing symptoms related to maternal tiredness. The use of nutrients like Folic Acid is relevant in the context of supporting these physiological phases.

Quick Fact: Supports management of symptoms related to heightened physiological activity

This use is relevant for easing the demand by supporting nutritional reserves before conception and providing continuous support afterward. This use is applied in situations where additional symptomatic support is needed, aligning with the goal of assisting with maintaining functional stability. The overall support provided is relevant for easing symptom clusters that may interfere with daily comfort due to the high metabolic turnover and nutrient demand.

Eligibility and Restrictions for Use

Who Can and Cannot Use Elevit Pronatal?

Eligibility for Elevit Pronatal is defined by official regulatory documents and relates strictly to a patient's physiological status, existing medical conditions, and age, with no consideration for therapeutic claims or benefits.

Approved Population Groups

The supplement is officially indicated and permitted for use by adult women and adolescent girls who are planning a pregnancy (pre-conception), who are pregnant, or who are breastfeeding (lactation).

Contraindications and Restrictions

Elevit Pronatal must not be used by individuals with known Hypersensitivity or allergy to any component. It is strictly contraindicated in patients with Severe impaired renal function, Hypercalcaemia, or Severe hypercalciuria. Use is also prohibited in patients with Hypervitaminosis D or pre-existing disorders of Iron and/or copper metabolism (e.g., Hemochromatosis).

Conditional use or caution is required for those with a history of Peptic Ulcer, Hepatic disease, or Nephrolithiasis (kidney stones). Use in the general pediatric population is not established.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Elevit Pronatal, a Multivitamin/Multimineral Complex, has officially documented interaction patterns primarily related to the chelation potential of its minerals and the pharmacodynamic effects of specific vitamins.

Official Interaction Statements

Interacting Substance/Class	Official Interaction Pattern
Levodopa	The Pyridoxine (Vitamin B6) component may lead to antagonism of Levodopa’s action.
Tetracycline & Fluoroquinolone Antibiotics	The mineral components (Iron, Zinc) reduce the absorption of these antibiotics via chelation.
Levothyroxine & Bisphosphonates	Reduced absorption is caused by chelation with the Iron and Calcium components.
Anticonvulsant Drugs	The Folic Acid component may cause decreased serum levels of co-administered anticonvulsant drugs.

Interaction-Related Restrictions and Timing Rules

Co-administration with other multivitamin or mineral supplements is officially restricted to avoid the risk of additive exposure and toxicity. Particular caution is required when the product is taken alongside fortified foods or products containing Vitamin D to prevent hypervitaminosis D.

To manage interactions that reduce absorption, mandatory timing separation is required: the supplement must be separated by at least 4 hours from Levothyroxine, and by at least 3 to 4 hours from Tetracycline antibiotics.

Mechanism of Action

The components of Elevit Pronatal, including multiple vitamins and minerals, serve as cofactors and substrates for biochemical processes, participating in enzymatic reactions across various maternal metabolic pathways. This foundational activity addresses the requirements of elevated cellular and physiological activity.

Vitamin A (retinol) acts as a ligand for nuclear receptors and modulates gene expression associated with cellular differentiation. Folic Acid (as methyltetrahydrofolate) functions as a methyl donor in the one-carbon metabolism pathway for de novo purine and pyrimidine synthesis (DNA/RNA).

Iron left( Fe^2+/ Fe^3+ ight) is incorporated into the porphyrin ring of the heme group, facilitating oxygen binding and transport. Iodine is required for the synthesis of the thyroid hormones triiodothyronine ( T3) and thyroxine ( T4).

Calcium ions left( Ca^2+ ight) act as structural components in hydroxyapatite formation, while Vitamin D upregulates intestinal absorption of Ca^2+ via 1,25( OH)2 D3-mediated genomic effects, influencing Ca^2+ homeostasis.

Dosage and Administration Information

How to Use Elevit Pronatal: Administration and Dosing

Elevit Pronatal is a multivitamin and multimineral complex intended for prophylactic nutritional support. This section details the administration and dosing for the preparation.

Dosing and Regimen

The medicine is administered via the oral route as a film-coated tablet. The standard dose and schedule are fixed and defined as follows:

Instruction	Guideline
Route of Administration	Oral only; tablet must be swallowed whole with water.
Standard Daily Dose	One tablet daily (1 cp./ j). This dose must not be exceeded.
Dosing Frequency	Once daily (q.d.).
Timing with Food	Preferably taken with a meal, such as breakfast, to enhance comfort and absorption. If morning sickness occurs, the tablet may be taken later in the day (e.g., noon or evening).

Treatment Duration and Specific Populations

Elevit Pronatal is used in a long-term, continuous pattern that spans the phases of high metabolic demand. Use should begin at least one month before planned conception to build nutritional reserves and should be continued throughout the entire pregnancy and lactation period.

Population Note: The adolescent dose is the same as the adult dose (one tablet daily). For women in the pre-conception phase who have not achieved pregnancy, the dosage may be adjusted in some instances, such as reducing intake to half a tablet daily or one tablet every two days. This structured use protocol ensures consistent delivery of micronutrients across the stages of maternal health.

Recent Clinical Evidence

Research evidence / Overview of studies for Elevit Pronatal

Evidence for use in Preventing Neural Tube Defects (NTDs)

The complex was studied for research focusing on early fetal development, particularly concerning the formation of the nervous system. The research base includes large-scale randomized controlled trials (RCTs) and systematic reviews, which research examined women in the period just before and immediately after conception (the periconceptional period). Studies monitored the rate of certain birth defects, such as spina bifida and anencephaly.

Studies reported measurements where the intake of the complex's Folic Acid component was observed alongside changes in maternal folate concentrations. The findings describe patterns observed in the studies where multivitamin-mineral complexes, often compared to placebo or no intervention, was associated with a lower incidence of NTDs. This evidence contributes to the broader evidence landscape which describes findings related to the Folic Acid component and this outcome.

The main body of high-level evidence focuses on the role of Folic Acid, and the specific contribution of the other vitamins and minerals in the complex to this particular outcome is not fully established. Furthermore, comparative evidence is lacking to definitively isolate the benefit of the entire complex against Folic Acid supplementation alone for NTD prevention.

Evidence for use in Nutritional Support during Pregnancy and Lactation

Research has explored outcomes related to nutritional status during periods of high physiological demand, such as pregnancy and breastfeeding. The evidence includes systematic reviews and controlled trials was evaluated in pregnant women across all trimesters and during the postpartum period. Researchers monitored outcomes related to systemic or functional imbalance, such as maternal hemoglobin concentration (a marker for anemia) and blood levels of essential micronutrients (like iron, zinc, and B vitamins).

Trials frequently evaluated the complex and observed patterns related to maternal hemoglobin levels and the status of several measured micronutrients when compared to control groups. Research highlights changes measured during the study period that contribute to understanding nutrient status in observed populations.

The evidence quality varies across studies, and the findings were mixed regarding broad clinical outcomes, as opposed to measurements of specific nutrient biomarkers. Follow-up durations were limited in many studies, meaning long-term effects are not fully established regarding maternal status during extended periods of lactation.

Evidence for use in Adverse Perinatal and Birth Outcomes

Multivitamin-mineral complexes was studied for their potential relevance to adverse perinatal and birth outcomes in infants. The research base involves large systematic reviews and meta-analyses of RCTs, which research examined outcomes such as low birth weight, preterm birth, and small-for-gestational age (SGA) in newborns.

Aggregated data describe patterns observed in the studies where complex use was associated with a lower incidence of some outcomes, such as SGA, particularly when was observed in populations with low baseline nutrient status. Findings regarding other outcomes, such as preterm birth or neonatal mortality, were mixed and data are still emerging across the full body of evidence.

Evidence is limited for generalized conclusions in well-nourished populations, as much of the most consistent research results apply only to the populations studied in low- and middle-income countries where baseline nutrient deficiencies are common. There is limited information for long-term outcomes that follow the child's development beyond the immediate postnatal period.

Evidence for use in Supporting the Reproductive Environment

Research explored the use of multivitamin-mineral complexes in women who were planning a pregnancy. These studies, typically smaller in scale than those focusing on NTDs, was evaluated in outcomes related to time-to-conception and the status of certain reproductive biochemical markers.

Reported findings describe patterns observed in the use of multivitamins and time-to-pregnancy in some populations. However, the available data was observed in some studies to be limited, often relying on intermediate measurements rather than clinical endpoints like live birth rates. Certainty remains low due to high variability in the formulations and populations studied.

Sample sizes were modest in many trials, and evidence is limited to draw broad conclusions about the impact of the complex on reproductive function for all women attempting to conceive. Subgroup findings are uncertain, as initial data suggests potential differences in effect based on maternal weight status, which requires further study.

Long-term Studies and Follow-up Durations

The available research describes the durations over which women and their infants was observed in key clinical trials. The most common follow-up intervals extend through the pregnancy term, with outcomes measured at delivery. Postnatal follow-up generally covers short-term intervals (up to six months postpartum).

Long-term effects are not fully established for this type of complex, meaning research is ongoing to understand the potential influence on child health and development beyond the first year of life. Follow-up durations were limited in many large-scale trials, focusing primarily on short-term markers of maternal nutritional status and immediate birth outcomes.

Consistency of Findings and Research Gaps

The evidence describes patterns of consistency observed between the Folic Acid component and NTD prevention. However, findings were mixed when evaluating the benefit of the multiple vitamins and minerals combined complex over standard Iron and Folic Acid supplementation alone across all adverse birth outcomes.

The research highlights what is known — and what is still uncertain. Key research limitation frames include small sample sizes in pre-conception studies, heterogeneity in findings across different countries and populations, and insufficient comparative evidence to definitively distinguish the complex from simpler iron and folate preparations in all clinical contexts. The overall evidence contributes to the broader evidence landscape by helping to contextualize what has been observed so far.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Elevit Pronatal (FAQ)

Q: Does Elevit Pronatal contain iodine, and why is that important?

A: Yes, Elevit Pronatal is officially noted to contain Iodine as part of its multimineral composition. According to official product information, Iodine is essential because it is required for the body to synthesize thyroid hormones, which are important for various metabolic processes.

Q: Is it still necessary to take Elevit Pronatal if I already eat a very healthy diet?

A: Official information frames the supplement's purpose as supporting the body's high nutritional demand during phases like preconception and pregnancy. This demand may exceed the intake from diet alone, even a healthy one. The multivitamin is intended to help maintain key nutritional reserves.

Q: Is it necessary to space out the intake of Elevit Pronatal from dairy products?

A: Current patient information does not specify a need to limit or separate the consumption of the multivitamin from dairy products. Mandatory timing separation is generally required only for specific medications that interact with the supplement's mineral components.

Q: Can certain foods or beverages affect how Elevit Pronatal is absorbed?

A: The official label requires that particular caution be exercised when the product is taken alongside fortified foods or products containing additional Vitamin D. This caution is advised to prevent potential over-exposure to these specific components.

Q: Does Elevit Pronatal contain Vitamin A, and is the amount considered safe in pregnancy?

A: Elevit Pronatal contains Vitamin A. Official warnings advise that the recommended dosage of the multivitamin complex must not be exceeded. The warning to not exceed the recommended dose applies to the complex as a whole, which contains multiple vitamins and minerals.

Q: What is the significance of the B-group vitamins included in the formulation?

A: The supplement includes a B-complex group to support various metabolic functions. Folic Acid, a key B vitamin, is specifically highlighted in official documents for its crucial function as a methyl donor in the process of DNA synthesis.

Q: Can the tablet be crushed or split if a user has difficulty swallowing?

A: Administration guidelines explicitly require the film-coated tablet to be swallowed whole with water. The official documentation does not include instructions for splitting or crushing the tablet.

Q: Is it safe to take Elevit Pronatal if I have a condition affecting my liver or digestive system?

A: Official eligibility criteria state that conditional use or caution is required for individuals with a history of Peptic Ulcer or Hepatic disease (liver disease). The supplement is contraindicated for individuals with certain pre-existing conditions, such as severe impaired renal function.

Q: Does the iron content in Elevit Pronatal affect stool color?

A: As with many supplements containing iron, patient information indicates that the iron component may cause stools to turn black. This effect is generally considered normal and is not harmful.

Q: Can taking Elevit Pronatal cause headaches or dizziness?

A: Yes, regulatory documents listing possible side effects include both headaches and dizziness. If unexpected or severe effects are experienced, individuals should consult with a healthcare provider.

Q: Is this product suitable for women with a history of anemia?

A: The supplement is intended for nutritional support during periods of high demand. Its iron component is positioned to help support blood production and oxygen transport, which is relevant when there is a risk of anemia.

Q: What are the known facts about the high iron dose in Elevit Pronatal?

A: The iron component is included because iron deficiency is common during pregnancy. The quantity supplied is intended to be essential for blood production and oxygen transportation to meet the elevated needs during this period.

Q: Does the official information mention any effect of Elevit Pronatal on energy levels?

A: Patient information suggests that the product may help relieve pregnancy-related side effects, including fatigue. This is consistent with its function of replenishing essential vitamins and minerals.

Q: What should be done if an occasional dose is forgotten?

A: General administration guidelines typically state that a missed dose may be taken as soon as possible. However, guidance advises against taking a double or extra dose if it is almost time for the next scheduled dose.

Q: Does Elevit Pronatal require a prescription to purchase in most regions?

A: Elevit Pronatal is classified as a multivitamin and multimineral nutritional supplement. Its classification as a nutritional supplement often leads to its availability over-the-counter (OTC).

Q: If a woman is using other herbal supplements, are there any known interaction risks with Elevit Pronatal?

A: Official documentation explicitly restricts co-administration with other multivitamin or mineral supplements. This restriction suggests general caution regarding combination use, which may extend to certain herbal supplements not listed in the drug interaction tables.

Q: How does the concentration of folic acid in Elevit Pronatal compare to standard recommendations?

A: The product contains a fixed amount of Folic Acid per tablet, which may vary slightly by regional formulation. This dosage is determined based on the intention to support the elevated requirement during the preconception and pregnancy periods.

Q: Are there different formulations of Elevit Pronatal available globally?

A: Regulatory documents show that while the core standard dose is one tablet daily, regional administration protocols can differ. Additionally, the manufacturer has introduced various product lines under the Elevit brand globally.

How should Elevit Pronatal be stored and disposed of?

Elevit Pronatal must be stored under specific environmental conditions to maintain its stability, as defined in official regulatory documents.

Storage Conditions

The product must be stored at a temperature not exceeding 30°C. It is essential to protect this product from light by storing it out of direct sunlight and in a dry, cool, well-ventilated area. The tablets must remain in the closed original container. These conditions support the labeled shelf life of 24 months.

Child Safety and Disposal

Elevit Pronatal must be stored out of the reach of children. Any unused medicinal product, as well as waste material and empty containers, must be disposed of in accordance with local requirements for pharmaceutical waste handling.

Elevit Pronatal